Qiushan Tao, MD

Research Assistant Professor, Pharmacology & Experimental Therapeutics

617.358.9565

Websites

Education

  • Henan Medical University, MD
  • Johns Hopkins University School of Public Health, MS
  • Huazhong University of Science and Techn, MS

Publications

  • Published on 10/15/2024

    Yuan J, Tao Q, Ang TFA, Liu C, Devine S, Auerbach SH, Mez J, Farrer LA, Qiu WQ, Au R. The Relationship between Framingham Stroke Risk Profile on Incident Dementia and Alzheimer's Disease: A 40-Year Follow-Up Study Highlighting Female Vulnerability. Ann Neurol. 2024 Oct 15. PMID: 39404028.

    Read at: PubMed
  • Published on 10/1/2024

    van Gils V, Tao Q, Ang TFA, Young CB, Mormino EC, Qiu WQ, Visser PJ, Au R, Jansen WJ, Vos SJB. Associations Between Glucose Metabolism Measures and Amyloid-ß and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study. Diabetes Care. 2024 Oct 01; 47(10):1787-1793. PMID: 39078159.

    Read at: PubMed
  • Published on 9/14/2024

    Zhang Z, Lin W, Gan Q, Lei M, Gong B, Zhang C, Henrique JS, Han J, Tian H, Tao Q, Potempa LA, Stein TD, Emili A, Qiu WQ. The influences of ApoE isoforms on endothelial adherens junctions and actin cytoskeleton responding to mCRP. Angiogenesis. 2024 Sep 14. PMID: 39276310.

    Read at: PubMed
  • Published on 7/29/2024

    Akhter-Khan SC, Tao Q, Ang TFA, Karjadi C, Itchapurapu IS, Libon DJ, Alosco M, Mez J, Qiu WQ, Au R. Cerebral Microbleeds in Different Brain Regions and Their Associations With the Digital Clock-Drawing Test: Secondary Analysis of the Framingham Heart Study. J Med Internet Res. 2024 Jul 29; 26:e45780. PMID: 39073857.

    Read at: PubMed
  • Published on 4/12/2024

    Wang Y, Huang J, Ang TFA, Zhu Y, Tao Q, Mez J, Alosco M, Denis GV, Belkina A, Gurnani A, Ross M, Gong B, Han J, Lunetta KL, Stein TD, Au R, Farrer LA, Zhang X, Qiu WQ. The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer's disease in the Framingham Heart Study. Explor Med. 2024; 5(2):193-214. PMID: 38854406.

    Read at: PubMed
  • Published on 1/1/2024

    Rehman H, Ang TFA, Tao Q, Espenilla AL, Au R, Farrer LA, Zhang X, Qiu WQ. Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status. J Alzheimers Dis. 2024; 97(2):621-633. PMID: 38143358.

    Read at: PubMed
  • Published on 10/16/2023

    Tao Q, Zhang C, Mercier G, Lunetta K, Ang TFA, Akhter-Khan S, Zhang Z, Taylor A, Killiany RJ, Alosco M, Mez J, Au R, Zhang X, Farrer LA, Qiu WWQ. Identification of an APOE e4-specific blood-based molecular pathway for Alzheimer's disease risk. Alzheimers Dement (Amst). 2023; 15(4):e12490. PMID: 37854772.

    Read at: PubMed
  • Published on 9/28/2023

    Huang J, Wang Y, Stein TD, Ang TFA, Zhu Y, Tao Q, Lunetta KL, Mez J, Au R, Farrer LA, Qiu WQ, Zhang X. The impact of blood MCP-1 levels on Alzheimer's disease with genetic variation of UNC5C and NAV3 loci. Res Sq. 2023 Sep 28. PMID: 37841863.

    Read at: PubMed
  • Published on 4/12/2023

    Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease. J Cereb Blood Flow Metab. 2023 Jul; 43(7):1027-1041. PMID: 37051650.

    Read at: PubMed
  • Published on 3/7/2023

    Na H, Yang JB, Zhang Z, Gan Q, Tian H, Rajab IM, Potempa LA, Tao Q, Qiu WQ. Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation. Neurobiol Aging. 2023 Jul; 127:54-69. PMID: 37060729.

    Read at: PubMed

View 47 more publications: View full profile at BUMC

View all profiles